Loading...
Practical aspects of extended half-life products for the treatment of haemophilia
Haemophilia A and haemophilia B are congenital X-linked bleeding disorders caused by deficiency of coagulation factor VIII (FVIII) and IX (FIX), respectively. The preferred treatment option for patients with haemophilia is replacement therapy. For patients with severe disease, prophylactic replaceme...
Na minha lista:
| Udgivet i: | Ther Adv Hematol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6130100/ https://ncbi.nlm.nih.gov/pubmed/30210757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718796429 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|